Details for 2019726240
Up to date per 09.04.2026
Actions
Details for 2019726240
Deleted
European Patent
10.03.2021 A
07.08.2024 B1
04.05.2018
US
201862667226 P
C07D 239/48 20060101AFI20201030BHEP
Owner
Alexion Pharmaceuticals, Inc.121 Seaport Boulevard Boston, MA 02210US
Representative
No representatives present
Inventor
PANDEY, Anjalic/o Portola Pharmaceuticals, Inc. 270 E. Grand Ave., Suite 22 South San Francisco, California 94080US
NORTHEN, Julian Scottc/o Onyx Scientific Limited, Silverbriar Enterprise Park East Sunderland, Tyne and Wear SR5 2TQGB
FERNANDES, Philippec/o Onyx Scientific Limited, Silverbriar Enterprise Park East Sunderland, Tyne and Wear SR5 2TQGB
CHEN, Yingc/o Portola Pharmaceuticals, Inc. 270 E. Grand Ave., Suite 22 South San Francisco, California 94080US
LU, Yuelie5115 Ruette De Mer San Diego, California 92130US
KARABORNI, Samic/o Portola Pharmaceuticals, Inc. 270 E. Grand Ave., Suite 22 South San Francisco, California 94080US
KODERSHA, Gusc/o Portola Pharmaceuticals, Inc. 270 E. Grand Ave., Suite 22 South San Francisco, California 94080US